DJ-1 and neurodegeneration: its roles in mitochondria and in protein misfolding

DJ-1 和神经变性:其在线粒体和蛋白质错误折叠中的作用

基本信息

  • 批准号:
    MR/L003503/1
  • 负责人:
  • 金额:
    $ 58.63万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2013
  • 资助国家:
    英国
  • 起止时间:
    2013 至 无数据
  • 项目状态:
    已结题

项目摘要

Parkinson's disease (PD), the second most common neurodegenerative disorder after Alzheimer's disease, is characterized by loss of dopaminergic neurons and the accumulation of misfolded alpha-synuclein in the form of Lewy bodies. The clinical symptoms include muscle rigidity, resting tremor, bradykinesia and postural instability as a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. At later stages, the etiology of neuronal loss in sporadic PD is unknown, although aberrant alpha-synuclein aggregation and oxidative stress may contribute to the death of specific neuronal populations. Although little is known about the pathogenesis of PD, the detailed study of several genes associated with familial PD is enhancing the understanding of the molecular mechanisms associated with the disease. Mutations in one of these genes - PARK7 - accounts for ~1-2% of the sporadic cases of early onset recessive PD. PARK7 encodes for DJ-1, a small conserved protein which is broadly expressed and primarily localized to the cytoplasm, but also found in the nucleus and associated with mitochondria. Despite the importance of this protein, the role of DJ-1 in in formation of PD remains unclear. Several functions have been suggested for DJ-1, including an oxidative stress sensor, a chaperone which deals with misfolded protein in the cells, and a regulator of mitochondrial function. In this project we seek to clarify how DJ-1 contributes to mitochondrial function and protein misfolding, and ultimately how defects in these cellular processes due to DJ-1 mutations contribute to pathogenesis in PD. For these studies we plan to implement immortalized cell lines, primary cells from mice, as well as fruit flies. In preliminary experiments we have observed that mutations in DJ-1 alter its ability to localize to mitochondria in mammalian cells under oxidative stress conditions. We thus now seek to further characterize this effect with varied oxidants, and also in the context of alpha-synuclein overexpression. In addition, we plan to investigate the impact of these mutants on both morphology and function of mitochondria in mouse cells, as well as the effects on mitochondrial gene expression. Finally we plan to extend this approach by studying the effect of DJ-1 mutants on the structure and function of mitochondria in fruit flies. Next we seek to further explore the role of DJ-1 in protein misfolding by investigating the relationship between DJ-1 and the Tau protein, which has been implicated in several neurodegenerative disorders. The Tau protein is involved in the pathogenesis of Alzheimer's disease and is a major component of neurofibrillary tangles present in this disorder. The gene encoding Tau has recently been genetically linked to PD. In addition, DJ-1 co-localizes with Tau inclusions in Alzheimer's disease and other brain disorders. However any possible physical/functional interactions between DJ-1 and Tau have not been studied and their relationship in the context of PD has not been explored. Thus we propose to study the interaction between DJ-1 and Tau in living mammalian cells, and to what extent, if any, this alters Tau toxicity or formation of fibers. Furthermore, we plan to extend this work to a fruit fly model of Tauopathies, to ascertain whether DJ-1 modulates disease-relevant "symptoms" in these animals. In preliminary work we have observed that DJ-1 and Tau directly interaction when expressed in mammalian cells. Thus, our work will better define the role of DJ-1 in mitochondrial function and in protein misfolding which will help clarify its pathogenic role in PD. This added insight into DJ-1 biology may ultimately help inform therapeutic strategies for this, and other, neurodegenerative disorders.
帕金森病是仅次于阿尔茨海默病的第二种常见的神经退行性疾病,其特征是多巴胺能神经元的丢失和以路易小体的形式错误折叠的α-突触核蛋白的积聚。临床症状包括肌肉僵硬、静止性震颤、运动迟缓和姿势不稳,这是由于黑质致密部多巴胺能神经元丢失所致。在后期阶段,散发性帕金森病的神经元丢失的病因尚不清楚,尽管异常的α-突触核蛋白聚集和氧化应激可能导致特定神经元群体的死亡。尽管人们对帕金森病的发病机制知之甚少,但对几个与家族性帕金森病相关的基因的详细研究正在加深对与该病相关的分子机制的理解。其中一个基因Park7的突变约占早发性隐性帕金森病散发性病例的1-2%。Park7编码DJ-1,这是一种小的保守蛋白,广泛表达,主要定位于细胞质,但也存在于细胞核中,与线粒体有关。尽管该蛋白很重要,但DJ-1在帕金森病形成中的作用尚不清楚。已经提出了DJ-1的几个功能,包括氧化应激传感器,处理细胞中错误折叠的蛋白质的伴侣,以及线粒体功能的调节器。在这个项目中,我们试图阐明DJ-1是如何参与线粒体功能和蛋白质错误折叠的,以及最终DJ-1突变导致的这些细胞过程中的缺陷是如何在PD的发病机制中起作用的。对于这些研究,我们计划实施永生化细胞系,来自小鼠的原代细胞,以及果蝇。在初步实验中,我们观察到在氧化应激条件下,DJ-1的突变改变了其定位于哺乳动物细胞线粒体的能力。因此,我们现在寻求用不同的氧化剂以及在α-突触核蛋白过度表达的背景下进一步表征这种效应。此外,我们计划研究这些突变体对小鼠细胞线粒体形态和功能的影响,以及对线粒体基因表达的影响。最后,我们计划通过研究DJ-1突变体对果蝇线粒体结构和功能的影响来扩展这种方法。接下来,我们试图通过研究DJ-1和Tau蛋白的关系来进一步探索DJ-1在蛋白质错误折叠中的作用,Tau蛋白与几种神经退行性疾病有关。Tau蛋白参与了阿尔茨海默病的发病机制,是这种疾病中神经原纤维缠结的主要成分。编码Tau的基因最近被认为与帕金森病有关。此外,DJ-1与Tau包涵体在阿尔茨海默病和其他大脑疾病中共同定位。然而,尚未研究DJ-1和Tau之间任何可能的物理/功能相互作用,也没有探讨它们在帕金森病背景下的关系。因此,我们建议研究DJ-1和Tau在活的哺乳动物细胞中的相互作用,以及这在多大程度上改变了Tau的毒性或纤维的形成。此外,我们计划将这项工作扩展到牛磺酸病的果蝇模型,以确定DJ-1是否调节这些动物的疾病相关“症状”。在前期工作中,我们观察到DJ-1和Tau在哺乳动物细胞中表达时直接相互作用。因此,我们的工作将更好地确定DJ-1在线粒体功能和蛋白质错误折叠中的作用,这将有助于阐明其在帕金森病发病中的作用。这增加了对DJ-1生物学的洞察,最终可能有助于为这种和其他神经退行性疾病的治疗策略提供参考。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane.
  • DOI:
    10.3390/biomedicines10092294
  • 发表时间:
    2022-09-15
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
  • 通讯作者:
Bypassing mitochondrial defects rescues Huntington's phenotypes in Drosophila
  • DOI:
    10.1016/j.nbd.2023.106236
  • 发表时间:
    2023-07-28
  • 期刊:
  • 影响因子:
    6.1
  • 作者:
    Campesan,Susanna;del Popolo,Ivana;Giorgini,Flaviano
  • 通讯作者:
    Giorgini,Flaviano
The Parkinson's Disease-Linked Protein DJ-1 Associates with Cytoplasmic mRNP Granules During Stress and Neurodegeneration.
  • DOI:
    10.1007/s12035-018-1084-y
  • 发表时间:
    2019-01
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    Repici M;Hassanjani M;Maddison DC;Garção P;Cimini S;Patel B;Szegö ÉM;Straatman KR;Lilley KS;Borsello T;Outeiro TF;Panman L;Giorgini F
  • 通讯作者:
    Giorgini F
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Flaviano Giorgini其他文献

Bypassing mitochondrial defects rescues Huntington's phenotypes in emDrosophila/em
绕过线粒体缺陷拯救了果蝇中的亨廷顿氏症表型
  • DOI:
    10.1016/j.nbd.2023.106236
  • 发表时间:
    2023-09-01
  • 期刊:
  • 影响因子:
    5.600
  • 作者:
    Susanna Campesan;Ivana del Popolo;Kyriaki Marcou;Anna Straatman-Iwanowska;Mariaelena Repici;Kalina V. Boytcheva;Victoria E. Cotton;Natalie Allcock;Ezio Rosato;Charalambos P. Kyriacou;Flaviano Giorgini
  • 通讯作者:
    Flaviano Giorgini
Understanding neuronal dysfunction and loss in neurodegenerative disease
  • DOI:
    10.1007/s00109-013-1053-x
  • 发表时间:
    2013-05-15
  • 期刊:
  • 影响因子:
    4.200
  • 作者:
    Flaviano Giorgini
  • 通讯作者:
    Flaviano Giorgini
The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease
  • DOI:
    10.1007/s00109-013-1046-9
  • 发表时间:
    2013-05-01
  • 期刊:
  • 影响因子:
    4.200
  • 作者:
    Marta Amaral;Tiago F. Outeiro;Nigel S. Scrutton;Flaviano Giorgini
  • 通讯作者:
    Flaviano Giorgini

Flaviano Giorgini的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Flaviano Giorgini', 18)}}的其他基金

EXPLORING THE ROLE AND THERAPEUTIC POTENTIAL OF RAB GTPASES IN HUNTINGTON'S DISEASE
探索 RAB GTP 酶在亨廷顿病中的作用和治疗潜力
  • 批准号:
    MR/R011621/1
  • 财政年份:
    2018
  • 资助金额:
    $ 58.63万
  • 项目类别:
    Research Grant
TARGETING PARKIN & MITOCHONDRIAL DYNAMICS IN HUNTINGTON'S DISEASE
瞄准帕金
  • 批准号:
    MR/M013847/1
  • 财政年份:
    2015
  • 资助金额:
    $ 58.63万
  • 项目类别:
    Research Grant
CHARACTERISING KYNURENINE 3-MONOOXYGENASE (KMO) AS A THERAPEUTIC TARGET FOR HUNTINGTON'S DISEASE
描述犬尿氨酸 3-单加氧酶 (KMO) 作为亨廷顿病治疗靶点的特征
  • 批准号:
    MR/N00373X/1
  • 财政年份:
    2015
  • 资助金额:
    $ 58.63万
  • 项目类别:
    Research Grant
Characterisation of candidate therapeutic targets for Huntington disease
亨廷顿病候选治疗靶点的表征
  • 批准号:
    G0700090/1
  • 财政年份:
    2008
  • 资助金额:
    $ 58.63万
  • 项目类别:
    Research Grant

相似国自然基金

探索PRAK与ARPC2的潜在相互作用及其在细胞自噬介导的神经萎缩中的功能和相关机制
  • 批准号:
    32000522
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
ESCRT蛋白Vps4在神经损伤引起的轴突自噬和沃勒变性中的作用和机制研究
  • 批准号:
    31970697
  • 批准年份:
    2019
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Vici综合征致病基因Epg5自噬缺陷的高通量筛选
  • 批准号:
    31900533
  • 批准年份:
    2019
  • 资助金额:
    26.0 万元
  • 项目类别:
    青年科学基金项目
酸性鞘磷脂酶缺陷导致神经退行性病变的分子机制
  • 批准号:
    30700219
  • 批准年份:
    2007
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Elucidation of the role of glutaminolysis in cellular senescence of glial cells and its contribution to age-associated neurodegeneration
阐明谷氨酰胺分解在神经胶质细胞衰老中的作用及其对年龄相关神经变性的贡献
  • 批准号:
    23K10827
  • 财政年份:
    2023
  • 资助金额:
    $ 58.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Extracellular vesicles in AD-like pathology in HIV and its potential therapeutics
HIV 中 AD 样病理学中的细胞外囊泡及其潜在治疗方法
  • 批准号:
    10618024
  • 财政年份:
    2023
  • 资助金额:
    $ 58.63万
  • 项目类别:
Advanced proteomics and microscopy to investigate protein trafficking in the endolysosomal system and its links with neurodegeneration
先进的蛋白质组学和显微镜技术研究内溶酶体系统中的蛋白质运输及其与神经退行性变的联系
  • 批准号:
    2898732
  • 财政年份:
    2023
  • 资助金额:
    $ 58.63万
  • 项目类别:
    Studentship
Brain signature of SARS-CoV-2 Infection and its impact on long-term cognitive functioning in older adults
SARS-CoV-2 感染的大脑特征及其对老年人长期认知功能的影响
  • 批准号:
    10650316
  • 财政年份:
    2022
  • 资助金额:
    $ 58.63万
  • 项目类别:
Characterizing vigilance in fMRI data and its relation to age-related cognitive impairment.
表征功能磁共振成像数据中的警惕性及其与年龄相关认知障碍的关系。
  • 批准号:
    10562847
  • 财政年份:
    2022
  • 资助金额:
    $ 58.63万
  • 项目类别:
Neurotoxicity of particulate matter and its interaction with APOE in neurodegeneration
颗粒物的神经毒性及其与 APOE 在神经变性中的相互作用
  • 批准号:
    10590465
  • 财政年份:
    2022
  • 资助金额:
    $ 58.63万
  • 项目类别:
A NexGenMo of AD for deficits in auditory learning, memory, and its rescue by manipulating plasticity in the auditory system
AD 的 NexGenMo,用于治疗听觉学习、记忆的缺陷,并通过操纵听觉系统的可塑性来挽救这种缺陷
  • 批准号:
    10287976
  • 财政年份:
    2021
  • 资助金额:
    $ 58.63万
  • 项目类别:
Exploring a new arm of the integrated stress response and its connection to neurodegeneration
探索综合应激反应的新分支及其与神经退行性变的联系
  • 批准号:
    10303995
  • 财政年份:
    2021
  • 资助金额:
    $ 58.63万
  • 项目类别:
Research on the Basic Properties of Chaotic Loewner Evolution and Its Application to Neuronal Morphology
混沌Loewner进化的基本性质及其在神经形态学中的应用研究
  • 批准号:
    20J20867
  • 财政年份:
    2020
  • 资助金额:
    $ 58.63万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Studying methionine flux and its role in aging and neurodegeneration
研究蛋氨酸通量及其在衰老和神经退行性疾病中的作用
  • 批准号:
    10410560
  • 财政年份:
    2019
  • 资助金额:
    $ 58.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了